Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays

Detection Principle
ImmunoAssay-Antibody
Target
IgG vs N (Epitope), IgG vs S1-RBD (Euroimmun)
Testing Method Category
ELISA
Testing Method
kits (Epitope, Euroimmun)
Testing Method - Additional Info
Epitope Diagnostics Inc. (EDI) (San Diego, CA) and Euroimmun ELISA (Lubeck, Germany)
Reported Performance
Sensitivity: 84.8% (Epitope), 91.8% (Euroimmun); Specificity: 99.1% (Epitope), 96.8% (Euroimmun)
Sample Size
228 samples (102 PCR positive, 20 other respiratory viruses, 106 pre-pandemic samples)
Peer-reviewed
yes

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements